543828 — Sudarshan Pharma Industries Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹2.89bn
- IN₹3.92bn
- IN₹4.64bn
- 39
- 40
- 85
- 56
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 12.5 | 2.36 | 117 | 16.4 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 604 | 735 | 815 | 1,225 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 876 | 1,296 | 1,986 | 2,416 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 59.8 | 68.8 | 190 | 224 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 993 | 1,375 | 2,325 | 2,831 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 712 | 1,010 | 1,185 | 1,608 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 768 | 1,077 | 1,315 | 1,714 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 225 | 298 | 1,010 | 1,117 |
Total Liabilities & Shareholders' Equity | 993 | 1,375 | 2,325 | 2,831 |
Total Common Shares Outstanding |